Fluoronaphthyridines and -quinolones as antibacterial agents. 3. Synthesis and structure-activity relationships of new 1-(1,1-dimethyl-2-fluoroethyl), 1-[1-methyl-1-(fluoromethyl)-2-fluoroethyl], and 1-[1,1-(difluoromethyl)-2-fluoroethyl] substituted derivatives. 1991

P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
Centre de Recherche Bristol-Myers Squibb, Lognes, Marne-La-Vallee, France.

A series of novel N-1-(mono-,-(di- and -(trifluoro-tert-butyl)quinolones and -naphthyridines has been prepared. Structure-activity relationship (SAR) studies indicated that the in vitro antibacterial potency was the following order: 1-(1,1-dimethyl-2-fluoroethyl) greater than 1-[1-methyl-1-(fluoromethyl)-2-fluoroethyl] greater than 1-[1,1-(difluoromethyl)-2-fluoroethyl] substituents. In the quinolone series the monofluoro-tert-butyl derivatives were found to possess better in vitro antibacterial activity than the nonfluorinated-tert-butyl equivalents. In vivo PD50 values of the 1-fluoro-tert-butyl-substituted derivatives reflect pharmacokinetic behavior and incomplete oral absorption.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009287 Naphthyridines A group of two-ring heterocyclic compounds consisting of a NAPHTHALENES double ring in which two carbon atoms, one per each ring, are replaced with nitrogens.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
October 1993, Journal of medicinal chemistry,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
January 2013, Molecules (Basel, Switzerland),
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
January 1988, Annals of the New York Academy of Sciences,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
September 1984, Journal of medicinal chemistry,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
April 1998, Chemical & pharmaceutical bulletin,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
November 1989, Arzneimittel-Forschung,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
November 1999, Journal of medicinal chemistry,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
November 2003, Archiv der Pharmazie,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
August 1998, Bioorganic & medicinal chemistry letters,
P Remuzon, and D Bouzard, and P D Cesare, and M Essiz, and J P Jacquet, and J R Kiechel, and B Ledoussal, and R E Kessler, and J Fung-Tomc
November 2007, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!